Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights

Issue Vol 2 Issue 6

Editorial
Commercial Insights

Cell & Gene Therapy Commercial Insight – November 2016

Commercial Insights

Mark Curtis & Richard Philipson Providing a critical overview of the sector’s commercial developments – M&As, licensing agreements & collaborations, financial results, IPOs and clinical/regulatory updates, with commentary from our Expert Contributors. CELL THERAPY: Atlas Venture and Third Rock launched Magenta Therapeutics with a $50 million series A this past month, perhaps the culmination of […]

Read full article »
Expert Insight

Analytical considerations for cellular therapy manufacturing

Spotlight Article

Expert Insight

The Cell & Gene Therapy Manufacturing Pathway: Part 4

Christopher Wiwi Latest advances in the analytical toolkit The commercialization of cell-based products presents unique challenges. An evolving regulatory landscape, rapid advances in manufacturing technologies, products with complex mechanisms of action (MOA) and inherent variability in starting cellular material are just a few examples of these challenges. The availability of relevant analytical tools is important […]

Read full article »

Understanding and managing sources of variability in cell measurements

Spotlight Article

Expert Insight

The Cell & Gene Therapy Manufacturing Pathway: Part 4

Sheng Lin-Gibson, Sumona Sarkar, John Elliott, Anne Plant Latest advances in the analytical toolkit Analytical methods are essential for establishing the quality attributes of cell-based products and for monitoring key steps during their production process. They also underpin the development of new cell therapy products (CTPs) by providing insight into biological mechanisms of action and […]

Read full article »

Requirement for smart in-process control systems to deliver cell therapy processes fit for the 21st century

Spotlight Article

Expert Insight

The Cell & Gene Therapy Manufacturing Pathway: Part 4

Damian Marshall, Stephen Ward & Marc-Olivier Baradez Latest advances in the analytical toolkit The cell therapy field continues to experience significant growth with an increasing number of therapies approaching commercialization and over 535 products currently undergoing phase II and III clinical trials [1]. This focus towards commercialization is leading cell therapy innovators to increasingly look […]

Read full article »
Innovator Insight

Product characterization: the evolving analytical toolkit

Spotlight Article

Innovator Insight

The Cell & Gene Therapy Manufacturing Pathway: Part 4

Latest advances in the analytical toolkit Dr Behnam A. Baghbaderani Dr Baghbaderani is the head of Cell Therapy Development, Emerging Technologies at Lonza. He has over 13 years of experience in stem cells engineering and bioprocessing. Dr. Baghbaderani holds a PhD degree in Biomedical Engineering from the University of Calgary (Calgary, Canada), where he developed […]

Read full article »
Twitter IconVisit Our Blog